HLB bioStep Co.,Ltd. (KOSDAQ:278650)

HLB bioStep Revenue

HLB bioStep had revenue of 13.49B KRW in the quarter ending March 31, 2026, a decrease of -0.68%. This brings the company's revenue in the last twelve months to 73.96B, up 22.89% year-over-year. In the year 2025, HLB bioStep had annual revenue of 74.05B with 27.30% growth.

• Revenue (ttm): 73.96B
• Revenue Growth: +22.89%
• P/S Ratio: 0.73
• Revenue / Employee: 503.11M
• Employees: 147
• Market Cap: 54.22B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	74.05B	15.88B	27.30%
Dec 31, 2024	58.17B	5.35B	10.14%
Dec 31, 2023	52.81B	-33.46B	-38.79%
Dec 31, 2022	86.28B	21.87B	33.96%
Dec 31, 2021	64.40B	5.88B	10.05%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 2, 2026

Data Sources Report a data error